Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | RPS16 |
| Upstream (Parents) |
|---|
| (<<) ACTB → RPS16 |
| (<<) CAT → RPS16 |
| (<<) CFL1 → RPS16 |
| (<<) DAZAP2 → RPS16 |
| (<<) ENO1 → RPS16 |
| (<<) PPP1CA → RPS16 |
| (<<) RHOA → RPS16 |
| (<<) RPL35 → RPS16 |
| Downstream (Children) |
|---|
| RPS16 → ACTN4 (>>) |
| RPS16 → AKT2 (>>) |
| RPS16 → ANKRD27 (>>) |
| RPS16 → ANXA2 (>>) |
| RPS16 → ATP2A2 (>>) |
| RPS16 → ATP2C2 (>>) |
| RPS16 → CDK8 (>>) |
| RPS16 → CDR2 (>>) |
| RPS16 → DISP2 (>>) |
| RPS16 → DUSP7 (>>) |
| RPS16 → EIF6 (>>) |
| RPS16 → FHIT (>>) |
| RPS16 → GAPDH (>>) |
| RPS16 → GLRX (>>) |
| RPS16 → GNAL (>>) |
| RPS16 → GRB2 (>>) |
| RPS16 → GSK3B (>>) |
| RPS16 → HDAC4 (>>) |
| RPS16 → HDAC8 (>>) |
| RPS16 → HES1 (>>) |
| RPS16 → HIF1A (>>) |
| RPS16 → HSPA8 (>>) |
| RPS16 → ID1 (>>) |
| RPS16 → JUN (>>) |
| RPS16 → KCNG1 (>>) |
| RPS16 → KLK7 (>>) |
| RPS16 → KLK8 (>>) |
| RPS16 → KYNU (>>) |
| RPS16 → MAL (>>) |
| RPS16 → MAP2K1 (>>) |
| RPS16 → MAP3K7 (>>) |
| RPS16 → MAP6D1 (>>) |
| RPS16 → MAPK9 (>>) |
| RPS16 → MT1F (>>) |
| RPS16 → MT1G (>>) |
| RPS16 → NDST1 (>>) |
| RPS16 → NFATC3 (>>) |
| RPS16 → NFKBIB (>>) |
| RPS16 → PAK4 (>>) |
| RPS16 → PFDN1 (>>) |
| RPS16 → PIK3C2B (>>) |
| RPS16 → PLD3 (>>) |
| RPS16 → PPIB (>>) |
| RPS16 → RASD1 (>>) |
| RPS16 → RPL36 (>>) |
| RPS16 → RTN3 (>>) |
| RPS16 → SERPINB1 (>>) |
| RPS16 → SIN3A (>>) |
| RPS16 → THOC4 (>>) |
| RPS16 → TMEM154 (>>) |
| RPS16 → YWHAG (>>) |
| RPS16 → ZNF554 (>>) |
